Cytokine storm and use of anakinra in a patient with COVID-19

We present a case of a 50-year-old man with COVID-19 infection and acute respiratory distress syndrome as a result of a cytokine storm and use of anakinra, an interleukin 1-receptor antagonist that is normally used in the treatment of autoinflammatory disorders in adult patients. We saw a reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemchand, Priyanka, Tahir, Hassan, Mediwake, Rapti, Lee, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493115/
https://www.ncbi.nlm.nih.gov/pubmed/32933914
http://dx.doi.org/10.1136/bcr-2020-237525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493115/
https://www.ncbi.nlm.nih.gov/pubmed/32933914
http://dx.doi.org/10.1136/bcr-2020-237525

Ejemplares similares